Nonneutralizing FVIII-specific antibody signatures in patients with hemophilia A and in healthy donors.
Journal
Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425
Informations de publication
Date de publication:
08 02 2022
08 02 2022
Historique:
received:
13
07
2021
accepted:
29
10
2021
pubmed:
1
12
2021
medline:
12
4
2022
entrez:
30
11
2021
Statut:
ppublish
Résumé
Previous studies identified nonneutralizing FVIII-specific antibodies in the circulation of severe and nonsevere hemophilia A (sHA and nsHA) patients without FVIII inhibitors and also in some healthy individuals. To gain a better understanding of the nature of these nonneutralizing antibody responses, we analyzed and compared anti-FVIII antibody signatures in 3 study cohorts: previously treated sHA as well as nsHA patients without FVIII inhibitors, and healthy donors. FVIII-binding IgM, IgG1-4, and IgA antibodies were differentiated, FVIII-specificity was assessed, and associated apparent affinity constants were determined. Our results indicate that the nonneutralizing FVIII-specific antibody response in all study cohorts is dominated by IgG1 and IgA. Prevalences, titers, and affinities of these nonneutralizing antibodies were higher in the hemophilia A cohorts than in healthy donors. Stratification for the anti-hepatitis C virus (HCV) antibody status demonstrated the presence of FVIII-specific IgA with elevated titers in sHA patients with an active or past HCV infection when compared with HCV antibody-positive nsHA patients or HCV antibody-negative patients and healthy donors. Increased titers and affinities of FVIII-specific IgG1 antibodies were observed in a considerable number of hemophilia A patients as opposed to healthy subjects independently of the patients' anti-HCV antibody status. Overall, our findings support the hypothesis that the generation of nonneutralizing anti-FVIII antibodies in healthy individuals and in noninhibitor hemophilia A patients might be based on similar immune mechanisms. However, differences in prevalences, titers, and affinities of these antibodies indicate distinct differences in the antibody evolution between healthy individuals and patients.
Identifiants
pubmed: 34847225
pii: 482837
doi: 10.1182/bloodadvances.2021005745
pmc: PMC8945293
doi:
Substances chimiques
Immunoglobulin A
0
Immunoglobulin G
0
Factor VIII
9001-27-8
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
946-958Informations de copyright
© 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Références
N Engl J Med. 2007 Aug 9;357(6):535-44
pubmed: 17687129
Ann Hematol. 1996 May;72(5):321-6
pubmed: 8645745
Ann N Y Acad Sci. 2005 Jun;1051:498-505
pubmed: 16126990
Nat Immunol. 2011 Dec 25;13(2):170-80
pubmed: 22197976
Haemophilia. 2018 Nov;24(6):921-929
pubmed: 30295389
Blood. 2013 Sep 12;122(11):1954-62
pubmed: 23926300
Blood Coagul Fibrinolysis. 2004 Mar;15(2):109-24
pubmed: 15090997
Clin Exp Immunol. 1996 Sep;105(3):537-43
pubmed: 8809146
Thromb Haemost. 1998 Apr;79(4):762-6
pubmed: 9569189
Blood. 2016 Jul 14;128(2):293-6
pubmed: 27216215
J Thromb Haemost. 2010 Oct;8(10):2224-31
pubmed: 20704648
Clin Exp Immunol. 2005 Jun;140(3):478-90
pubmed: 15932509
Nat Rev Immunol. 2002 May;2(5):323-35
pubmed: 12033738
Haemophilia. 2011 Nov;17(6):884-9
pubmed: 21447095
Pharm World Sci. 2008 Jun;30(3):287-92
pubmed: 18085428
Haemophilia. 2020 Aug;26 Suppl 6:1-158
pubmed: 32744769
Haemophilia. 2020 May;26(3):487-493
pubmed: 32329553
Br J Haematol. 2012 Jun;157(6):747-52
pubmed: 22533635
Curr Top Microbiol Immunol. 2014;382:221-35
pubmed: 25116102
Semin Thromb Hemost. 2000;26(2):157-65
pubmed: 10919408
Annu Rev Immunol. 2003;21:177-204
pubmed: 12524384
Annu Rev Immunol. 1994;12:991-1045
pubmed: 8011301
Biologicals. 2001 Sep-Dec;29(3-4):229-32
pubmed: 11851320
Nat Rev Immunol. 2019 Feb;19(2):89-103
pubmed: 30464294
Expert Opin Biol Ther. 2019 Aug;19(8):801-810
pubmed: 31039049
Br J Haematol. 1996 Jun;93(3):688-93
pubmed: 8652395
Immunol Rev. 2003 Aug;194:8-18
pubmed: 12846803
J Clin Immunol. 2010 Jan;30(1):1-9
pubmed: 19834792
Blood. 1997 May 15;89(10):3663-71
pubmed: 9160671
Nat Rev Immunol. 2013 Feb;13(2):118-32
pubmed: 23348416
Blood. 2007 Aug 1;110(3):815-25
pubmed: 17446349
Blood. 2009 Mar 12;113(11):2587-94
pubmed: 19144987
J Thromb Haemost. 2011 Oct;9(10):1948-58
pubmed: 21838755
Immunity. 2002 Sep;17(3):341-52
pubmed: 12354386
Nat Immunol. 2014 Jul;15(7):631-7
pubmed: 24880458
Haemophilia. 2003 Jul;9(4):418-35
pubmed: 12828678
N Engl J Med. 2016 May 26;374(21):2054-64
pubmed: 27223147
Front Immunol. 2020 Jan 10;10:2991
pubmed: 31998296
J Exp Med. 1976 Nov 2;144(5):1227-42
pubmed: 825608
N Engl J Med. 2013 Jan 17;368(3):231-9
pubmed: 23323899
Thromb Haemost. 1995 Feb;73(2):247-51
pubmed: 7792738
Br J Haematol. 2017 Mar;176(5):796-804
pubmed: 28198996
Sci Immunol. 2019 Mar 1;4(33):
pubmed: 30824527
Crit Rev Immunol. 2018;38(2):145-158
pubmed: 29887727
J Immunol Methods. 2007 Dec 1;328(1-2):53-8
pubmed: 17884083
Blood. 2017 Mar 9;129(10):1245-1250
pubmed: 28034891
Blood. 2015 Feb 12;125(7):1180-8
pubmed: 25515962
Thromb Haemost. 2011 Jun;105(6):954-61
pubmed: 21475776
J Autoimmun. 2007 Dec;29(4):246-9
pubmed: 17888625
Nat Rev Immunol. 2005 Aug;5(8):606-16
pubmed: 16056254
Haemophilia. 2014 Nov;20(6):e406-8
pubmed: 25311419
Haemophilia. 2010 Jan;16(1):20-32
pubmed: 19845775
Blood. 1994 Mar 1;83(5):1278-88
pubmed: 8118031
J Thromb Haemost. 2020 Dec;18(12):3203-3210
pubmed: 32877570
Front Immunol. 2020 May 07;11:563
pubmed: 32457734
Nat Immunol. 2000 Jul;1(1):31-6
pubmed: 10881171
Semin Thromb Hemost. 2002 Jun;28(3):291-6
pubmed: 12098091
BMJ Open. 2019 Apr 23;9(4):e022719
pubmed: 31015264
J Immunol. 2015 Jan 15;194(2):606-14
pubmed: 25480561
Nat Rev Immunol. 2001 Dec;1(3):177-86
pubmed: 11905826
Blood Adv. 2020 Nov 24;4(22):5785-5796
pubmed: 33232473
Haemophilia. 2012 Mar;18(2):263-7
pubmed: 21851507
J Thromb Haemost. 2014 Nov;12(11):1935-9
pubmed: 25059285
Blood. 2013 Feb 7;121(6):1039-48
pubmed: 23243272
Annu Rev Immunol. 2009;27:267-85
pubmed: 19302041
Immunol Rev. 2019 Mar;288(1):128-135
pubmed: 30874357
Blood. 2016 Oct 20;128(16):2055-2067
pubmed: 27381905
Thromb Diath Haemorrh. 1975 Nov 15;34(2):612
pubmed: 1198543
J Mol Recognit. 2010 Sep-Oct;23(5):448-56
pubmed: 20033900
Immunity. 2001 May;14(5):617-29
pubmed: 11371363
J Thromb Haemost. 2003 Jun;1(6):1228-36
pubmed: 12871324